2021 Covid-19 Vaccines Update
In December we published a report on up and coming Covid-19 Vaccines from around the world. This month we are publishing an update on approved Covid 19 Vaccines and promising Covid-19 Vaccine candidates that have reached phase 3 clinical trials. We have indicated background information, Trial Design, their status for each.
This report is co-published with the Clinical Research Consultancy CRO, McDougall Scientific and provided to you in a format that is hopefully useful to digest. All clinical trial data, summaries, content and references have been referenced directly from clinicaltrials.gov provided by the National Institutes of Health, by the Regulatory Affairs Professionals Society (RAPS), the New York Times Coronavirus Vaccine Tracker, and by CNN Health.
Download the 2021 Covid-19 Vaccines report
With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.
Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.
